2013Unpublished venueRequires access

COMPUTER AIDED DRUG DESIGNING AND DEVELOPMENT OF NEW NON- STEROIDAL ANTI-INFLAMMATORY DRUGS CONSIDERING MEFENAMIC ACID/ DICLOFENAC AS A LEAD COMPOUND FOLLOWED BY THEIR SYNTHESIS AND EVALUATION

Sampatrao B. Suryaawanshi, G. M. Nazeruddin

Open publisher page 3 citations

Abstract

Discovery of new and new non-steroidal anti-inflammatory drug (NSAID) always has attracted greater attention over the years. In the present work series of derivatives of Mefenamic acid and Diclofenac (known non-steroidal anti-inflammatory drugs) were designed and different physicochemical properties were calculated such as Log P, H-Donor, H-Acceptor, Molecular weight and P ka.and these properties are compared with Diclofenac / Mefenamic Acid. All the new non-steroidal anti-inflammatory drugs (NSAID) selected for designing have to follow Lipinski's Rule of Five. Out of them seven compounds having similar physicochemical properties were selected for the synthesis. They were found to have potential anti-inflammatory activity.

About this research paper

What this paper is about

Discovery of new and new non-steroidal anti-inflammatory drug (NSAID) always has attracted greater attention over the years. In the present work series of derivatives of Mefenamic acid and Diclofenac (known non-steroidal anti-inflammatory drugs) were designed and different physicochemical properties were calculated such as Log P, H-Donor, H-Acceptor, Molecular weight and P ka.and these properties are compared with Diclofenac / Mefenamic Acid. All the new non-steroidal anti-inflammatory drugs (NSAID) selected for designing have to follow Lipinski's Rule of Five. Out of them seven compounds having similar physicochemical properties were selected for the synthesis. They were found to have potential anti-inflammatory activity.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Discovery of new and new non-steroidal anti-inflammatory drug (NSAID) always has attracted greater attention over the years. In the present work series of derivatives of Mefenamic acid and Diclofenac (known non-steroidal anti-inflammatory drugs) were designed and different physicochemical properties were calculated such as Log P, H-Donor, H-Acceptor, Molecular weight and P ka.and these properties are compared with Diclofenac / Mefenamic Acid. All the new non-steroidal anti-inflammatory drugs (NSAID) selected for designing have to follow Lipinski's Rule of Five. Out of them seven compounds having similar physicochemical properties were selected for the synthesis. They were found to have potential anti-inflammatory activity.

Key concepts: Mefenamic acid, Diclofenac, Anti-inflammatory, Lipinski's rule of five, Drug, Chemistry, Pharmacology, Diclofenac Sodium

Related papers

Back to paper searchBrowse research topicsOriginal source
COMPUTER AIDED DRUG DESIGNING AND DEVELOPMENT OF NEW NON- STEROIDAL ANTI-INFLAMMATORY DRUGS CONSIDERING MEFENAMIC ACID/ DICLOFENAC AS A LEAD COMPOUND FOLLOWED BY THEIR SYNTHESIS AND EVALUATION — Research Paper | ScholarLens